GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (STU:C6K0) » Definitions » Float Percentage Of Total Shares Outstanding

Avalo Therapeutics (STU:C6K0) Float Percentage Of Total Shares Outstanding : 100.40% (As of Jun. 03, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Avalo Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Avalo Therapeutics's float shares is 1.03 Mil. Avalo Therapeutics's total shares outstanding is 1.03 Mil. Avalo Therapeutics's float percentage of total shares outstanding is 100.40%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Avalo Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Avalo Therapeutics's Institutional Ownership is 0.96%.

Avalo Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Avalo Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=1.03/1.03
=100.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avalo Therapeutics (STU:C6K0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (STU:C6K0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
KALA FBRX TCRT EQ PMCB FRES IGC AKTX MYMD NTRB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
AVTX:USA C6K0:Germany
Address
540 Gaither Road, Suite 400, Rockville, MD, USA, 20850
Website
https://www.avalotx.com
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Avalo Therapeutics (STU:C6K0) Headlines

No Headlines